Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05945212

Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.

The aim of the vibration intervention proposed in the current study is to allow a better neuromotor recovery in subacute stroke patients when compared with standard rehabilitation alone. These last years, it has been proven that the solicitation of a muscle using vibrations may lead to positive effects on the neuromuscular function. Thus, the aim of the current study is to assess if the addition to a standard rehabilitation program of local vibrations sessions of the dorsiflexor muscles of the paretic limb of stroke patients may allow a better recovery of walking speed (primary outcome). One group using vibrations (i.e. experimental group) and one group with sham vibration (i.e. control group) will take part to this study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Georges Claudinon, Le Chambon-Feugerolles, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke)
  • Presenting with a stroke, ischemic or hemorrhagic
  • Lower-limb deficiency with an initial motor testing < 4 according to the MRC scale
  • No neurological history with functional impact other than stroke
  • Having received informed information about the study and having signed the written consent
  • Affiliated or entitled to a social security scheme.
  • Patients under guardianship may be included; they may give their consent with the assistance of their guardian.

If the participant is unable to write, their consent may be given and documented by other appropriate means in the presence of at least one impartial witness. In this case, the witness will sign and date the informed consent document.

Exclusion criteria

  • Multiple stroke
  • Other neurological, cognitive or psychiatric conditions
  • Orthopedic ankle history compromising measurements
  • Botulinum toxin injected in the lower limb prior the study protocol
  • Patient with phlebitis or risk of thrombosis in the lower limb
  • Patient under tutorship

Treatment and study plan

Vibration

Device

The program will take place over 40 sessions : 5 sessions per week, for 2 months (40 sessions in total over 8 weeks during the hospitalization in the department); this group will benefit from an effective vibration of a frequency of 100Hz

Other names: VIBRAMOOV PHYSIO

Sham vibration

Device

The program will take place over 40 sessions: 5 sessions per week, for 2 months (40 sessions in total over 8 weeks during hospitalization in the department); this group will not benefit from effective vibration.

10 meters Walk Test

Other

Short-distance ambulation speed is measurement between 2 markers on the ground 10 meters apart in a corridor with flat ground, the patient starting his walk 3 meters before to have a launched march disregarding markers, and ends 3 meters After. The stopwatch is started when the markers are crossed.

2 Minute Walk Test (2MWT)

Other

Long-distance ambulation speed is measured from a standing start and the test involves asking the patient to walk as far as possible in 2 minutes.

Fugl-Meyer (FMA-LE)

Other

The Fugl-Meyer (FMA-LE) assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination. Score from 0 to 34

Modified Ashworth scale

Other

The modified Ashworth scale allows the measurement of spasticity, that is to say the measurement of muscle tone by mobilizing the segment of the lower limb and by evaluating the resistance to stretching of the muscles. Score from 0 to 4

ABILOCO questionnaire

Other

The ABILOCO questionnaire evaluate the autonomy in the walking capacities of the patients (13-items)

Barthel index

Other

The Barthel index measure autonomy in daily life.

isometric ergometer

Other

Evaluate voluntary maximum force in isometric ankle dorsiflexion by Cybex isometric ergometer results.

Other names: Cybex isometric ergometer (Henley Healthcare, Sugarland, TX, USA)

Electromyograms (EMG)

Other

Assessment of neuromuscular fatigue by electromyograms (EMG). Surface electrodes is place on the tibial muscle anterior to non-invasively collect electromyograms (EMG). The intensity of stimulation will be gradually increased until a plateau in mechanical (strength) and electromyograms (EMG) responses is obtained.

Other names: Electrodes Meditrace 100, Covidien, Mansfield, MA

Traditional quantified gait analysis

Other

Gait kinematics will be recorded on a force platform (90 x 90 cm, Model 9287C, Kistler, Winterthur, Switzerland) to determine: joint angles, net joint moments and powers at the ankle, knee and hip.

Other names: 0D

SPM - Statistical Parametric Mapping

Other

Addition of a temporal component to the traditional quantified gait analysis, allowing the focus to be on time series parameters.

Other names: 1D

FACIT questionnaire (Functional Assessment of Chronic Illness Therapy)

Other

A short questionnaire consisting of 13 questions to which the patient answers on a scale from 0 to 4. The scores are simply added up, inverting the scale for negative sentences, to give a result out of 52 points. The lower the score, the greater the fatigue.

Primary outcomes

  1. Gait speed by 10 meters Walk Test (in meter /second) results

    Time frame: Month 2

    Analysis Gait speed by 10 meters Walk Test (in meter /second) results

Secondary outcomes

  1. Walking performance by 10 meters Walk Test (in meter /second) results

    Time frame: Month 0, 1, 2, 3, 4

    Analysis Walking performance (comfort speed) by 10 meters Walk Test (in meter /second) results

  2. Walking performance by 2 Minute Walk Test (2MWT) (in meter) results

    Time frame: Month 0, 1, 2, 3, 4

    Analysis Walking performance (distance) by 2 Minute Walk Test (2MWT) (in meter) results

  3. Walking performance by Quantified Gait Analysis results

    Time frame: Month 2, 4

    Walking performance will be assessed using: (in m/s) in the 10-meter test (short distance), distance (in m) covered in a 2-minute walk test (long distance) , and qualitatively by a Quantified Gait Analysis (performed only in M2 and M4).

  4. Motor function of the paretic lower limb

    Time frame: Month 4

    The motor function of the paretic lower limb will be measured by the Fugl Meyer Assessment scale for lower limbs (FMA-LE) which includes five domains: Motor skills; Balance skills; Sensitivity; Range of motion; Joint pain. A three-point ordinal scale (0: cannot perform; 1: partially performed; 2: fully performed) is applied to each item. The maximum score is 226.

  5. Lower limb spasticity level

    Time frame: Month 4

    The level of spasticity of the lower limb will be measured by the modified Ashworth scale : a 6-point scale with scores ranging from 0 to 4, where the lowest scores represent normal muscle tone and the highest scores represent spasticity or increased resistance to passive movement.

  6. Autonomy in walking activities

    Time frame: Month 4

    The patient's autonomy in walking activities will be measured by the ABILOCO questionnaire and in daily living activities by the Barthel index.

  7. Lower limb strength

    Time frame: Month 4

    Lower extremity strength will be measured as maximal voluntary strength in isometric ankle dorsiflexion.

  8. Neuromuscular fatigue (1)

    Time frame: Month 4

    Neuromuscular fatigue will be assessed by the level of voluntary activation (in %).

  9. Neuromuscular fatigue (2)

    Time frame: Month 4

    Neuromuscular fatigue will be assessed by corticospinal and intracortical excitability thanks to electromyographic responses evoked by transcranial magnetic stimulation.

  10. Neuromuscular fatigue (3)

    Time frame: Month 4

    Neuromuscular fatigue will be assessed by spinal excitability thanks to electromyographic responses evoked by electrical nerve stimulation.

  11. Neuromuscular fatigue (4)

    Time frame: Month 4

    Neuromuscular fatigue will be assessed by perceived subjective fatigue measured by the FACIT questionnaire : the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System is a collection of health-related quality of life (HRQOL) questionnaires targeted to the management of chronic illness, including over 400 questions. Higher scores for the scales and subscales indicate better quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Bruno FERNANDEZ, MD

CONTACT

[email protected]

(0)477120638 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Collaborators

  • Ministry of Health, France

Registry information

Official study title

Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients - a Multicentric Randomized Controlled Study

Acronym: NEUROVIB-AVC

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jul 14, 2023
Registry last updated
Dec 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.